162 related articles for article (PubMed ID: 7912504)
21. Hepatitis B virus-related polyarteritis nodosa and membranous nephropathy.
Mouthon L; Deblois P; Sauvaget F; Meyrier A; Callard P; Guillevin L
Am J Nephrol; 1995; 15(3):266-9. PubMed ID: 7618654
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.
Guillevin L; Lhote F; Gayraud M; Cohen P; Jarrousse B; Lortholary O; Thibult N; Casassus P
Medicine (Baltimore); 1996 Jan; 75(1):17-28. PubMed ID: 8569467
[TBL] [Abstract][Full Text] [Related]
23. Polyarteritis nodosa related to hepatitis B virus. A retrospective study of 66 patients.
Guillevin L; Lhote F; Jarrousse B; Bironne P; Barrier J; Deny P; Trepo C; Kahn MF; Godeau P
Ann Med Interne (Paris); 1992; 143 Suppl 1():63-74. PubMed ID: 1363769
[TBL] [Abstract][Full Text] [Related]
24. Changes in serum and histology of patients with chronic hepatitis B after interferon alpha-2b treatment.
Han HL; Lang ZW
World J Gastroenterol; 2003 Jan; 9(1):117-21. PubMed ID: 12508364
[TBL] [Abstract][Full Text] [Related]
25. [Polyarteritis nodosa related to hepatitis b virus infection].
Demolin G; Delwaide J; Van Severen M; Demolin H; Cornet G; Belaiche J
Rev Med Liege; 1999 Dec; 54(12):921-4. PubMed ID: 10686797
[TBL] [Abstract][Full Text] [Related]
26. Systemic vasculitis in patients with hepatitis C.
Cacoub P; Maisonobe T; Thibault V; Gatel A; Servan J; Musset L; Piette JC
J Rheumatol; 2001 Jan; 28(1):109-18. PubMed ID: 11196510
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B associated fulminant polyarteritis nodosa: successful treatment with pulse cyclophosphamide, prednisolone and lamivudine following emergency surgery.
Lau CF; Hui PK; Chan WM; Fung TT; Tung YM; Loo CK; Yip WC; Lam KM
Eur J Gastroenterol Hepatol; 2002 May; 14(5):563-6. PubMed ID: 11984157
[TBL] [Abstract][Full Text] [Related]
29. [Recommendations of diagnosis and treatment of polyarteritis nodosa].
Mansur M; Da ZY; Guo JT; Wu LJ; Zhao Y
Zhonghua Nei Ke Za Zhi; 2022 Jul; 61(7):749-755. PubMed ID: 35764557
[TBL] [Abstract][Full Text] [Related]
30. Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients.
Guillevin L; Fain O; Lhote F; Jarrousse B; Le Thi Huong D; Bussel A; Leon A
Arthritis Rheum; 1992 Feb; 35(2):208-15. PubMed ID: 1346499
[TBL] [Abstract][Full Text] [Related]
31. Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. The Cooperative Study Group for Polyarteritis Nodosa.
Guillevin L; Jarrousse B; Lok C; Lhote F; Jais JP; Le Thi Huong Du D; Bussel A
J Rheumatol; 1991 Apr; 18(4):567-74. PubMed ID: 1676753
[TBL] [Abstract][Full Text] [Related]
32. Treatment of polyarteritis nodosa and Churg-Strauss angiitis: indications of plasma exchange. Results of three prospective trials in 162 patients. The Cooperative Study Group for the Study of Polyarteritis Nodosa.
Guillevin L
Prog Clin Biol Res; 1990; 337():309-17. PubMed ID: 1972283
[No Abstract] [Full Text] [Related]
33. Management of virus-induced systemic vasculitides.
Guillevin L; Cohen P
Curr Rheumatol Rep; 2002 Feb; 4(1):60-6. PubMed ID: 11798984
[TBL] [Abstract][Full Text] [Related]
34. HBV-related cutaneous periarteritis nodosa in a patient 16 years after renal transplantation: efficacy of lamivudine.
Bedani PL; Bergami M; Cavazzini PL; Strumia R; Morelli MC; Stabellini G; Gilli P
J Nephrol; 2001; 14(5):428-30. PubMed ID: 11730280
[TBL] [Abstract][Full Text] [Related]
35. Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype.
Flink HJ; van Zonneveld M; Hansen BE; de Man RA; Schalm SW; Janssen HL;
Am J Gastroenterol; 2006 Feb; 101(2):297-303. PubMed ID: 16454834
[TBL] [Abstract][Full Text] [Related]
36. Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis.
Trepo C; Guillevin L
J Autoimmun; 2001 May; 16(3):269-74. PubMed ID: 11334492
[TBL] [Abstract][Full Text] [Related]
37. [Periarteritis nodosa induced by hepatitis B virus].
Mouthon L
Pathol Biol (Paris); 1999 Mar; 47(3):237-44. PubMed ID: 10214615
[TBL] [Abstract][Full Text] [Related]
38. Regressing microaneurysms in 5 cases of hepatitis B virus related polyarteritis nodosa.
Darras-Joly C; Lortholary O; Cohen P; Brauner M; Guillevin L
J Rheumatol; 1995 May; 22(5):876-80. PubMed ID: 8587075
[TBL] [Abstract][Full Text] [Related]
39. Interferon and ribavirin treatment results of patients with HBV-HCV co-infection cured of childhood malignancies.
Urganci N; Gulec S; Dogan S; Nuhoglu A
Int J Infect Dis; 2006 Nov; 10(6):453-7. PubMed ID: 17000127
[TBL] [Abstract][Full Text] [Related]
40. Manifestation of cutaneous polyarteritis nodosa during interferon therapy for chronic hepatitis C associated with primary biliary cirrhosis.
Dohmen K; Miyamoto Y; Irie K; Takeshita T; Ishibashi H
J Gastroenterol; 2000; 35(10):789-93. PubMed ID: 11063225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
